Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome
- 1 October 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 63 (2), 354-361
- https://doi.org/10.1016/j.ijrobp.2005.02.030
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancerThe British Journal of Radiology, 2004
- Cisplatin-based combined modality therapy for anal carcinomaCancer, 2003
- Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic MalignanciesGynecologic Oncology, 2001
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group studyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Treatment planning at the University of North Carolina at Chapel HillSeminars in Radiation Oncology, 1992
- Definitive Irradiation and Chemotherapy for Radiosensitization in Management of Anal Carcinoma: Interim Report on Radiation Therapy Oncology Group Study No. 8314JNCI Journal of the National Cancer Institute, 1989
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1981
- Combined treatment of squamous cell carcinoma of the anal canalDiseases of the Colon & Rectum, 1980